Tao Cheng
Ankang, 725000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Study the inhibition impact of Folic acid-Bi2O3-MgO NPs on HCT116 colorectal cancer cells by inducing cytotoxic, cell migration and antioxidant assay.
Journal: Tissue & cell
Published: June 26, 2026
HMBOX1 plays a critical role in plumbagin-induced growth inhibition of hepatocellular carcinoma cells.
Journal: Scientific reports
Published: July 31, 2025
MiR-532-3p suppresses cell proliferation, migration and invasion of colon adenocarcinoma via targeting FJX1.
Journal: Pathology, research and practice
Published: June 27, 2021
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
Journal: Radiation oncology (London, England)
Published: December 30, 2020
Stereotactic Body Radiation Therapy vs. Transarterial Chemoembolization in Inoperable Barcelona Clinic Liver Cancer Stage a Hepatocellular Carcinoma: A Retrospective, Propensity-Matched Analysis.
Journal: Frontiers in oncology
Published: October 29, 2019
Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy.
Journal: Radiation oncology (London, England)
Published: January 23, 2019
A prospective cohort study of hepatic toxicity after stereotactic body radiation therapy for hepatocellular carcinoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 30, 2017
Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: October 10, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026